Eventide Asset Management »

Arcus Biosciences Incorporated shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6M 240k 19.10
2023-09-30 $4.3M 240k 17.95
2023-06-30 $4.9M 240k 20.31
2023-03-31 $4.4M 240k 18.24
2022-12-31 $5.0M 240k 20.68

More positions owned by Eventide Asset Management

Xometry Class A Com (XMTR)
Trane Technologies SHS (TT)
Zentalis Pharmaceuticals (ZNTL)
Old Dominion Freight Line (ODFL)
Celldex Therapeutics Com New (CLDX)
Roper Industries (ROP)
Crowdstrike Hldgs Cl A (CRWD)
IDEXX Laboratories (IDXX)
Palo Alto Networks (PANW)
Waste Connections (WCN)
D.R. Horton (DHI)
Pool Corporation (POOL)
Guardant Health (GH)
Global E Online SHS (GLBE)
Flywire Corporation Com Vtg (FLYW)

View all positions for Eventide Asset Management

Top funds holding Arcus Biosciences Incorporated

Vanguard Group
Octagon Capital Advisors
Dimensional Fund Advisors
Invus Financial Advisors
Boxer Capital
Alliancebernstein
Decheng Capital
Point72 Asset Management
Bnp Paribas Investment Partners
Goldman Sachs Group
Balyasny Asset Management
Susquehanna International
Charles Schwab Investment Management
Bank of New York Mellon
Ikarian Capital

View all funds holding Arcus Biosciences Incorporated